Alternative names (1)
hasBlackBoxWarningRandom triples
| Subject | Object |
|---|---|
| gptkb:Reglan | tardive dyskinesia |
| gptkb:Vitrakvi | no |
| gptkb:Venclexta | gptkb:tumor_lysis_syndrome |
| gptkb:relmacabtagene_autoleucel | cytokine release syndrome |
| gptkb:axicabtagene_ciloleucel | yes |
| gptkb:lisocabtagene_maraleucel | neurological toxicities |
| gptkb:Zohydro_ER | addiction, abuse, and misuse |
| gptkb:Hysingla_ER | accidental ingestion |
| gptkb:DB12173 | No |
| gptkb:Eylea | endophthalmitis risk |
| gptkb:Xeljanz | serious infections |
| gptkb:Serzone | liver failure |
| gptkb:Risperdal | increased mortality in elderly patients with dementia-related psychosis |
| gptkb:Cyclophosphamide | myelosuppression |
| gptkb:Etanercept | malignancy |
| gptkb:Braftovi | none |
| gptkb:Zyprexa | increased risk of death in elderly patients with dementia-related psychosis |
| gptkb:Abecma | neurologic toxicities |
| gptkb:Clozaril | myocarditis |
| gptkb:DB14081 | increased risk of thrombotic events after premature discontinuation |